144 related articles for article (PubMed ID: 27230035)
1. MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt.
Yang W; Yang Y; Xia L; Yang Y; Wang F; Song M; Chen X; Liu J; Song Y; Zhao Y; Yang C
Cell Physiol Biochem; 2016; 38(6):2366-74. PubMed ID: 27230035
[TBL] [Abstract][Full Text] [Related]
2. MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2.
Wang YD; Mao JD; Wang JF; Xu MQ
Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
Xu H; Zhu J; Hu C; Song H; Li Y
J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
8.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
9. miR-382 targeting PTEN-Akt axis promotes liver regeneration.
Bei Y; Song Y; Wang F; Dimitrova-Shumkovska J; Xiang Y; Zhao Y; Liu J; Xiao J; Yang C
Oncotarget; 2016 Jan; 7(2):1584-97. PubMed ID: 26636539
[TBL] [Abstract][Full Text] [Related]
10. RETRACTED: miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.
Li B; Lu Y; Wang H; Han X; Mao J; Li J; Yu L; Wang B; Fan S; Yu X; Song B
Biomed Pharmacother; 2016 Apr; 79():93-101. PubMed ID: 27044817
[TBL] [Abstract][Full Text] [Related]
11. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
Deng J; He M; Chen L; Chen C; Zheng J; Cai Z
PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.
Wu YR; Qi HJ; Deng DF; Luo YY; Yang SL
Tumour Biol; 2016 Sep; 37(9):12061-12070. PubMed ID: 27188433
[TBL] [Abstract][Full Text] [Related]
14. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
15. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
[TBL] [Abstract][Full Text] [Related]
16. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
17. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
[TBL] [Abstract][Full Text] [Related]
18. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
Weng M; Luo ZL; Wu XL; Zeng WZ
Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
[TBL] [Abstract][Full Text] [Related]
19. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
Han GY; Cui JH; Liang S; Li HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
[TBL] [Abstract][Full Text] [Related]
20. MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling.
Mziaut H; Henniger G; Ganss K; Hempel S; Wolk S; McChord J; Chowdhury K; Ravassard P; Knoch KP; Krautz C; Weitz J; Grützmann R; Pilarsky C; Solimena M; Kersting S
Mol Metab; 2020 Jan; 31():150-162. PubMed ID: 31918917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
